We are live on ! Find out more
RKDA icon

Arcadia Biosciences
RKDA

16 hedge funds and large institutions have $11.6M invested in Arcadia Biosciences in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% less funds holding

Funds holding: 20 → 16 (-4)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

27% less capital invested

Capital invested by funds: $15.9M → $11.6M (-$4.27M)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
16
Holders Change
-4
Holders Change %
-20%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$42.4K
2
Goldman Sachs
Goldman Sachs
New York
+$28.3K
3
Citadel Advisors
Citadel Advisors
Florida
+$23K
4
TRCT
Tower Research Capital (TRC)
New York
+$10.6K
5
Bank of America
Bank of America
North Carolina
+$5.3K

Top Sellers

Rank Fund Capital Flow
1
WRF
Waddell & Reed Financial
Kansas
-$129K
2
PP
Paloma Partners
Connecticut
-$81K
3
CS
Credit Suisse
Switzerland
-$49K
4
Millennium Management
Millennium Management
New York
-$35K
5
LRPA
L. Roy Papp & Associates
Arizona
-$15.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
WRF
1
Waddell & Reed Financial
Kansas
$10.3M -$129K -73 -1%
LRPA
2
L. Roy Papp & Associates
Arizona
$718K -$15.9K -9 -2%
BCM
3
Bridgeway Capital Management
Texas
$144K – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$127K +$42.4K +24 +41%
Norges Bank
5
Norges Bank
Norway
$86K – – –
BFA
6
BlackRock Fund Advisors
California
$68K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$50K – – –
Goldman Sachs
8
Goldman Sachs
New York
$44K +$28.3K +16 +123%
Citadel Advisors
9
Citadel Advisors
Florida
$19K +$23K +13 New
TRCT
10
Tower Research Capital (TRC)
New York
$10K +$10.6K +6 New
Bank of America
11
Bank of America
North Carolina
$9K +$5.3K +3 +100%
UBS Group
12
UBS Group
Switzerland
$7K -$1.77K -1 -17%
FMA
13
FNY Managed Accounts
New York
$4.09K -$5.3K -3 -50%
BIM
14
BlackRock Investment Management
Delaware
$4K – – –
Wells Fargo
15
Wells Fargo
California
$4K – – –
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$1K – – –
PP
17
Paloma Partners
Connecticut
– -$81K -39 Closed
CS
18
Credit Suisse
Switzerland
– -$49K -24 Closed
Millennium Management
19
Millennium Management
New York
– -$35K -17 Closed
Barclays
20
Barclays
United Kingdom
– -$14K -7 Closed
New York State Common Retirement Fund
21
New York State Common Retirement Fund
New York
– -$6K -3 Closed
Morgan Stanley
22
Morgan Stanley
New York
– -$1K -1 Closed

RKDA Hedge Fund Activity: Q3 2016 in Review

16 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q3 2016, worth a combined $11.6M — down 27% from $15.9M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of RKDA and 2 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 3 added.

The largest buyer was Vanguard Group, adding an estimated $42.4K. The largest seller was Waddell & Reed Financial, cutting an estimated $129K.

  • 16 institutional investors held Arcadia Biosciences (RKDA) as of Q3 2016, down from 20 in Q2 2016.
  • Funds reported $11.6M of Arcadia Biosciences stock for Q3 2016, down 27% quarter-over-quarter.
  • 2 funds opened new Arcadia Biosciences positions in Q3 2016 and 6 closed out, a net change of -4 holders.
  • The largest Arcadia Biosciences buyer in Q3 2016 was Vanguard Group, an estimated $42.4K added.
  • The largest Arcadia Biosciences seller in Q3 2016 was Waddell & Reed Financial, an estimated $129K sold.

Based on aggregated 13F filings for Q3 2016.